Sanofi Ventures is the corporate venture capital arm of Sanofi, a global biopharmaceutical company. It focuses on investing in innovative startups and companies that are developing transformative therapies and technologies across various stages of development. The firm seeks to build a portfolio that aligns with Sanofi's strategic interests and leverages the parent company's expertise to support the growth of its investments.

Sanofi Ventures

Solbosch provides a variety of medical and paramedical specialties. It is equipped with a viral air purifier.

Solbosch

Ablynx develops NANOBODY® technology, which enables the creation of new therapeutics and the refinement of existing treatments. The technology utilizes miniature, engineered antibodies derived from camelids, allowing for the design of multi-targeting therapies.

Ablynx

AI in Pharma: Discovery is focused on exploring the applications of AI-based technology in drug discovery and development, specifically how AI, ML, NLP, data science, and generative deep learning models can optimize the pharmaceutical and biotechnology industries.

Metric
Company Name	Sanofi Ventures	Solbosch	Ablynx	AI in Pharma: Discovery
Symbol
MSH ID	COM:SANOFIVENTURES	BE:SOLBOSCH	COM:ABLYNX	COM:AIINPHARMA-DISCOVERY
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Pharmaceuticals	Healthcare	Biotechnology	Pharmaceuticals
Country		BE	BE	US
Stage
Employee Count
Website	sanofiventures.com	solbosch.be	ablynx.com	aiinpharma-discovery.com
LinkedIn		le-solbosch
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	586
Web Traffic Growth	-0.36
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SANO

COM:SANOFIVENTURES

Sanofi Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue